During the past decade, Carolina Phase 1 Research conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolina Phase 1 Research" #1 collaborator was "Kimberly-Clark Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Carolina Phase 1 Research" are "Rheumatoid Arthritis" (2 trials), "Atopic Dermatitis" (1 trials), "Chronic Rhinosinusitis With Nasal Polyps" (1 trials), "Clostridium Difficile" (1 trials) and "Diabetes Melliuts, Type 2" (1 trials). Many other conditions were trialed in "Carolina Phase 1 Research" in a lesser frequency.

Most popular intervention types in "Carolina Phase 1 Research" are "Drug" (5 trials), "Biological" (2 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "100 mg PF-05231023" (1 trials), "150 mg PF-05231023" (1 trials), "25 mg PF-05231023" (1 trials) and "50 mg PF-05231023" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carolina Phase 1 Research" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Carolina Phase 1 Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Carolina Phase 1 Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Carolina Phase 1 Research, 7 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".